MedTrace Logo

Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From Depression

NCT04448431 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 605

Last updated 2022-02-14

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy of vortioxetine versus desvenlafaxine after 8 weeks of treatment in patients that have tried one available treatment without getting the full benefit

Conditions

Interventions

DRUG

Vortioxetine

10 or 20 mg/day, capsules, orally

DRUG

Desvenlafaxine

50 mg/day capsules, orally

Sponsors & Collaborators

  • H. Lundbeck A/S

    lead INDUSTRY

Principal Investigators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-18
Primary Completion
2022-01-06
Completion
2022-02-04

Countries

  • Argentina
  • Belgium
  • Bulgaria
  • Czechia
  • Estonia
  • Latvia
  • Mexico
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • Ukraine

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04448431 on ClinicalTrials.gov